Transdermal fentanyl for cancer pain (Q24197559)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6517042&resulttype=core&format=json

14 May 2020

2

Sheena Derry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6517042&resulttype=core&format=json

14 May 2020

3

R Andrew Moore

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6517042&resulttype=core&format=json

14 May 2020

1

Gina Hadley

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6517042&resulttype=core&format=json

Cochrane Database of Systematic Reviews

14 May 2020

publication date

5 October 2013

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6517042&resulttype=core&format=json

14 May 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6517042&resulttype=core&format=json

14 May 2020

page(s)

CD010270

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6517042&resulttype=core&format=json

Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group

14 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010270.PUB2

Transdermal fentanyl for pain control in adults with chronic cancer pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010270.PUB2

A randomized, open, parallel group, multicenter trial to investigate analgesic efficacy and safety of a new transdermal fentanyl patch compared to standard opioid treatment in cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010270.PUB2

Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010270.PUB2

Radiotherapy plus either transdermal fentanyl or paracetamol and codeine for painful bone metastases: a randomised study of pain relief and quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010270.PUB2

Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010270.PUB2

Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010270.PUB2

Transdermal opioids for cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010270.PUB2

Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010270.PUB2

The number needed to treat: a clinically useful measure of treatment effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010270.PUB2

Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010270.PUB2

Transdermal fentanyl in cachectic cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010270.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010270.PUB2

Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010270.PUB2

Benefit-Risk Assessment of Transdermal Fentanyl for the Treatment of Chronic Pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010270.PUB2

Meta-analysis in clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010270.PUB2

Transdermal fentanyl: clinical pharmacology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010270.PUB2

Improved cancer pain treatment using combined fentanyl-TTS and tramadol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010270.PUB2

Dural permeability to narcotics: in vitro determination and application to extradural administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010270.PUB2

Size is everything--large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010270.PUB2

Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010270.PUB2

Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010270.PUB2

Adverse effects of transdermal opiates treating moderate-severe cancer pain in comparison to long-acting morphine: a meta-analysis and systematic review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010270.PUB2

Transdermal opioids as front line treatment of moderate to severe cancer pain: a systemic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010270.PUB2

Impact of covert duplicate publication on meta-analysis: a case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010270.PUB2

Oral morphine for cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010270.PUB2

Comparison of transdermal fentanyl with codeine/paracetamol, in combination with radiotherapy, for the management of metastatic bone pain

21 January 2018

1 reference

12 December 2020

The pharmacologic management of cancer pain

1 reference

12 December 2020

Comparison of TD-fentanyl with sustained-release morphine in the pain treatment of patients with lung cancer

1 reference

12 December 2020

Can observational studies provide a realistic alternative to randomized controlled trials in palliative care?

1 reference

12 December 2020

A systematic review of randomized trials on the effectiveness of opioids for cancer pain

1 reference

12 December 2020

Comparison of oral controlled-release morphine with transdermal fentanyl in terminal cancer pain

1 reference

12 December 2020

10.1002/14651858.CD010270.PUB2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6517042&resulttype=core&format=json

14 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6517042&resulttype=core&format=json

14 May 2020

PubMed publication ID

24096644

1 reference